Skip to Main Content

Here you can browse the complete list of publications for NLST

Publication Year
Title PubMed Authors Journal Year Studies
Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare. 25943596 Roth JA, Sullivan SD, Goulart BH, Ravelo A, Sanderson JC, Ramsey SD J Oncol Pract 2015 NLST
Cost-effectiveness of Lung Cancer Screening in Canada. 26226181 Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK JAMA Oncol 2015 NLST
Airflow Limitation and Histology-shift in the National Lung Screening Trial: the NLST-ACRIN Cohort Substudy (N=18, 714). 26199983 Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D Am. J. Respir. Crit. Care Med. 2015 NLST
Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals. 25837734 Fitzgerald NR, Flanagan WM, Evans WK, Miller AB, Canadian Partnership against Cancer (CPAC) Cancer Risk Management (CRM) Lung Cancer Working Scand J Work Environ Health 2015 NLST
Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. 26372542 Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ Cancer 2015 NLST
Brain Imaging for Staging of Patients with Clinical Stage IA Non-Small Cell Lung Cancer in the National Lung Screening Trial: Adherence with Recommendations From the Choosing Wisely Campaign. 26356134 Balekian AA, Fisher JM, Gould MK Chest 2015 NLST
The Association Between Smoking Abstinence and Mortality in the National Lung Screening Trial. 26502000 Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, Egede LE, Silvestri GA Am. J. Respir. Crit. Care Med. 2015 NLST
Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. 26712960 Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER Oncologist 2015 NLST
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. 26602092 Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V Urol. Oncol. 2015 NLST, PLCO
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. 26238115 Gohagan JK, Prorok PC, Greenwald P, Kramer BS Rev Recent Clin Trials 2015 NLST, PLCO
Bayesian Estimation of the Three Key Parameters in CT for the National Lung Screening Trial Data Ruiqi Liu, Beth Levitt, Tom Riley, Dongfeng Wu J Biom Biostat 2015 NLST
Computer-Assisted Diagnosis of Lung Cancer Using Quantitative Topology Features Jiawen Yao , Dheeraj Ganti , Xin Luo , Guanghua Xiao , Yang Xie , Shirley Yan , Junzhou Huang MLMI 2015 2015 NLST
Culturally sensitive approaches to recruitment and retention of Hispanics in the national lung screening trial. 23780349 Tenorio SL, O'Donnell CI, Hernandez J, Rozjabek HM, Lynch D, Marcus PM J Immigr Minor Health 2014 NLST
Overdiagnosis in low-dose computed tomography screening for lung cancer. 24322569 Patz EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammem├Ągi MC, Chiles C, Black WC, Aberle DR, NLST Overdiagnosis Manuscript Writing Team JAMA Intern Med 2014 NLST
National Lung Screening Trial Findings by Age: Medicare-Eligible Versus Under-65 Population. 25199624 Pinsky PF, Gierada DS, Hocking W, Patz EF, Kramer BS Ann. Intern. Med. 2014 NLST
Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. 25192282 O'Grady TJ, Kitahara CM, DiRienzo AG, Boscoe FP, Gates MA PLoS ONE 2014 NLST, PLCO
The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. 25089376 Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP, International Early Lung Cancer Investigators Eur. J. Cancer Prev. 2014 NLST
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. 25065710 Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C Cancer 2014 NLST
Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. 25044253 Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y Urol. Oncol. 2014 NLST, PLCO
Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. 24979231 McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ PLoS ONE 2014 NLST